ONCORUS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 24th, 2023 • Oncorus, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 24th, 2023 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”), effective as of February 11, 2022 (the “Effective Date”), is made by and among Oncorus, Inc., a Delaware corporation (the “Company”) and John Goldberg, M.D. (the “Executive” and, together with the Company, the “Parties”), and amends and restates in its entirety the Offer Letter between the Company and Executive that was effective as of September 7, 2018.
ONCORUS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • February 9th, 2021 • Oncorus, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), which shall be effective as of December 7, 2020 subject to the appointment by the Company’s Board of Directors (the “Board”) of the Executive as the Company’s Chief Operating Officer and Chief of Staff (the “Effective Date”), is made by and among Oncorus, Inc., a Delaware corporation (the “Company”) and Steve Harbin (“Executive” and, together with the Company, the “Parties”).
ONCORUS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 28th, 2020 • Oncorus, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 28th, 2020 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”), effective as of the IPO Closing Date (the “Effective Date”), is made by and among Oncorus, Inc., a Delaware corporation (the “Company”) and Ted T. Ashburn, M.D., Ph.D. (“Executive” and, together with the Company, the “Parties”), and amends and restates in its entirety the Employment Agreement between the Company and Executive that was effective as of July 16, 2018.
ONCORUS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 28th, 2020 • Oncorus, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 28th, 2020 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”), effective as of the IPO Closing Date (the “Effective Date”), is made by and among Oncorus, Inc., a Delaware corporation (the “Company”) and John McCabe (“Executive” and, together with the Company, the “Parties”), and amends and restates in its entirety the Offer Letter between the Company and Executive that was effective as of July 29, 2019.
ONCORUS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 28th, 2020 • Oncorus, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 28th, 2020 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”), effective as of the IPO Closing Date (the “Effective Date”), is made by and among Oncorus, Inc., a Delaware corporation (the “Company”) and Christophe Queva (“Executive” and, together with the Company, the “Parties”), and amends and restates in its entirety the Offer Letter between the Company and Executive that was effective as of October 2, 2017.